Niacin Cures Systemic NAD+ Deficiency and Improves Muscle Performance in Adult-Onset Mitochondrial Myopathy.

@article{Pirinen2020NiacinCS,
  title={Niacin Cures Systemic NAD+ Deficiency and Improves Muscle Performance in Adult-Onset Mitochondrial Myopathy.},
  author={Eija Pirinen and Mari Auranen and Nahid Ahmed Khan and Virginia Brilhante and Niina Urho and Alberto Pessia and Antti Hakkarainen and Juho Kuula and Ulla Heinonen and Mark S. Schmidt and Kimmo Haimilahti and P{\"a}ivi Liisa Piiril{\"a} and Nina Lundbom and Marja-Riitta Taskinen and Charles Brenner and Vidya R. Velagapudi and Kirsi H Pietil{\"a}inen and Anu Suomalainen},
  journal={Cell metabolism},
  year={2020}
}

Figures from this paper

NAD+-Increasing Strategies to Improve Cardiometabolic Health?
TLDR
The characteristics of the latest clinical trials testing the therapeutic potential of different vitamin B3 molecules to improve cardiometabolic health are dissected, with a special focus on randomized, placebo-controlled clinical trials performed in the context of obesity or other pathologies.
NAD+ Metabolism in Cardiac Health, Aging, and Disease.
TLDR
It is surmise that patients with hitherto intractable cardiac diseases such as heart failure with preserved ejection fraction may profit from the administration of NAD+ precursors, and outstanding questions on the optimal design of clinical trials in which NAD+ replenishment or supraphysiological NAD+ elevations are assessed for the prevention or treatment of major cardiac diseases are raised.
NAD+ Precursors and Antioxidants for the Treatment of Amyotrophic Lateral Sclerosis
TLDR
This review analyzes different antioxidant molecules or NAD+ generators proposed for the therapy of ALS not only in light of their use as individual molecules, but with special emphasis on their potential association, and even as part of broader combined multi-therapies.
NAD+ homeostasis in human health and disease
TLDR
The state of the art of the potential therapeutic implications of NAD+ repletion for boosting health as well as treating rare and common diseases, and the possibilities to achieve this by means of the different NAD+‐enhancing agents are discussed.
NAD+-Precursor Supplementation With L-Tryptophan, Nicotinic Acid, and Nicotinamide Does Not Affect Mitochondrial Function or Skeletal Muscle Function in Physically Compromised Older Adults
TLDR
The findings are consistent with previous findings on NAD+ efficacy in humans, and show in community-dwelling, older adults with impaired physical function that NAD+-precursor supplementation through L-tryptophan, nicotinic acid, and nicotinamide does not improve mitochondrial or skeletal muscle function.
Nicotinamide riboside improves muscle mitochondrial biogenesis, satellite cell differentiation and gut microbiota composition in a twin study
TLDR
It is suggested that NR acts as a potent modifier of NAD+ metabolism, muscle mitochondrial biogenesis and stem cell function, gut microbiota, and DNA methylation in humans irrespective of BMI.
Enhance Trial: Effects of NAD3® on Hallmarks of Aging and Clinical Endpoints of Health in Middle Aged Adults: A Subset Analysis Focused on Blood Cell NAD+ Concentrations and Lipid Metabolism
TLDR
First-in-human data demonstrate a theacrine-based NAD3 supplement can favorably alter biomarkers of lipid metabolism and cellular NAD+ status, however, the latter data are limited to targeted NAD+ metabolites, and the effects of supplementation on other cellular metabolites or mechanisms related to the observed outcomes need to be further explored.
Nicotinamide Riboside alleviates exercise intolerance in ANT1-deficient mice
TLDR
Treating ANT1-deficient mice with nicotinamide riboside increased NAD+ levels in skeletal muscle and improved the exercise capacity and mitochondrial respiration, indicating the therapeutic potential of NAD+-stimulating compounds in specific mitochondrial myopathies.
The NADase enzyme CD38: an emerging pharmacological target for systemic sclerosis, systemic lupus erythematosus and rheumatoid arthritis
TLDR
Recent studies identify potential therapeutic approaches for boosting NAD+ to treat rheumatologic diseases including SSc, RA, and SLE, with particular attention to inhibition of CD38 enzymatic activity as a target.
...
...

References

SHOWING 1-10 OF 73 REFERENCES
NAD+ repletion improves muscle function in muscular dystrophy and counters global PARylation
TLDR
The authors suggest that NAD+ repletion may be a successful therapeutic approach for a number of muscle-wasting diseases and suggest that the replenishment of NAD+ may benefit patients with muscular dystrophies or other neuromuscular degenerative conditions characterized by the PARP/NNMT gene expression signatures.
Effective treatment of mitochondrial myopathy by nicotinamide riboside, a vitamin B3
TLDR
NR effectively delayed early‐ and late‐stage disease progression, by robustly inducing mitochondrial biogenesis in skeletal muscle and brown adipose tissue, preventing mitochondrial ultrastructure abnormalities and mtDNA deletion formation, suggesting its protective role in mitochondrial disease.
NAD+ repletion improves mitochondrial and stem cell function and enhances life span in mice
TLDR
It is demonstrated the importance of the amount of the oxidized form of cellular nicotinamide adenine dinucleotide (NAD+) and its effect on mitochondrial activity as a pivotal switch to modulate muscle SC (MuSC) senescence and it is demonstrated that NR delays senescences of neural SCs and melanocyteSCs and increases mouse life span.
Mitochondrial oxidative capacity and NAD+ biosynthesis are reduced in human sarcopenia across ethnicities
TLDR
A fundamental role of altered mitochondrial metabolism in the pathological loss of skeletal muscle mass and function in older people is demonstrated, associated with reduced mitochondria numbers and lower NAD+ levels in older individuals with sarcopenia.
Eliciting the mitochondrial unfolded protein response by nicotinamide adenine dinucleotide repletion reverses fatty liver disease in mice
TLDR
It is demonstrated that NR prevents and reverts NAFLD by inducing a sirtuin (SIRT)1‐ and SIRT3‐dependent mitochondrial unfolded protein response, triggering an adaptive mitohormetic pathway to increase hepatic β‐oxidation and mitochondrial complex content and activity.
Modified Atkins diet induces subacute selective ragged‐red‐fiber lysis in mitochondrial myopathy patients
TLDR
Results indicate that nutrition can modify mitochondrial disease progression, dietary counseling should be part of MM care, short mAD is a tool to induce targeted RRF lysis, and mAD, a common weight‐loss method, may induce muscle damage in a population subgroup.
...
...